Standard BioTools Inc. (LAB) Stock Overview
NASDAQ · Healthcare · Medical Devices
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Standard BioTools Inc.
Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company…
Source: Yahoo Finance
Sector & Industry
Standard BioTools Inc. operates in the Healthcare sector, within the Medical Devices industry group. It is listed on the NASDAQ exchange.
Standard BioTools Inc. at a Glance
| Company | Standard BioTools Inc. |
| Ticker | LAB |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $0.69 |
| Market cap | $269.11M |
| P/E ratio (trailing) | — |
| EPS (trailing) | -$0.13 |
| 52-week high | $1.72 |
| 52-week low | $0.63 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 1.37 |
| Return on equity (ROE) | -11.18% |
| Debt-to-equity | 5.20% |
| Average volume | 3.21M |
| Shares outstanding | 392.58M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Employees | 385 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Frequently Asked Questions
- What is Standard BioTools Inc.'s current P/E ratio?
- Standard BioTools Inc. (LAB) has a trailing P/E ratio of — as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Standard BioTools Inc.'s market capitalisation?
- Standard BioTools Inc.'s market cap is $269.11M based on our latest snapshot. See how it ranks by market cap →
- What is LAB's 52-week range?
- Over the past 52 weeks, LAB has traded between $0.63 and $1.72. What does the 52-week range mean? →
- How volatile is Standard BioTools Inc. compared to the market?
- Standard BioTools Inc. has a beta of 1.37, meaning it has historically moved more than the broader market. What does beta measure? →
- Does Standard BioTools Inc. pay a dividend?
- Standard BioTools Inc. does not currently pay a dividend according to our latest data.
- What exchange is LAB listed on?
- LAB is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is Standard BioTools Inc. in?
- Standard BioTools Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
Prefer raw numbers at a glance? Browse our size and reference charts for quick lookups.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →